Search company, investor...

Founded Year

2021

Stage

Incubator/Accelerator | Alive

Total Raised

$2.25M

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

-50 points in the past 30 days

About Gesund.ai

Gesund.ai focuses on the development and deployment of clinical-grade artificial intelligence within the healthcare domain. The company offers a platform that aids medical artificial intelligence developers in creating, validating, and maintaining their AI solutions to ensure compliance, efficiency, and scalability. It primarily serves the healthcare technology industry by providing AI assurance and facilitating AI research and development cycles. The company was founded in 2021 and is based in Cambridge, Massachusetts.

Headquarters Location

47 Thorndike Street

Cambridge, Massachusetts, 02141,

United States

Loading...

Gesund.ai's Product Videos

Gesund.ai's Products & Differentiators

    Validation-as-a-Service

    We run our customers' existing AI models against case-specific data annotated by board-certified physicians to create evidence for regulatory clearance purposes.

Loading...

Research containing Gesund.ai

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Gesund.ai in 1 CB Insights research brief, most recently on Jul 2, 2024.

Expert Collections containing Gesund.ai

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Gesund.ai is included in 3 Expert Collections, including Digital Health.

D

Digital Health

11,109 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

A

AI 100 (2024)

100 items

A

Artificial Intelligence

6,888 items

Latest Gesund.ai News

Gesund.ai Open Sources Evaluation Library to Standardize Performance and Safety of Clinical AI

Oct 21, 2024

Called Gesund Validate, it is the only validation methodologies and frameworks library built with board-certified physician-annotated data following FDA guidelines The library includes testing methodologies used for bias evaluation across virtually all FDA-approved AI products and includes more than 20 clinically valid healthcare validation metrics Launch comes as federal law makes medical providers and payors legally responsible for preventing ensuing from use of clinical AI solutions Boston, MA – WEBWIRE – Monday, October 21, 2024 Gesund.ai , the clinical AI validation company, today announced the open sourcing of a comprehensive library of evaluation methodologies and frameworks to help developers and users address AI performance and potential bias across patient cohorts for the FDA-regulated AI solutions on the market. As part of its mission to standardize AI validation, Gesund.ai is also announcing it has joined the Coalition for Health AI, after partnering with public and private industry groups like CancerX, the NIST AI Safety Institute Consortium, VALID AI and the American Heart Association. Clinical AI products have special characteristics that must be accounted for when screening them for potential bias. For instance, beyond the data itself, the laws themselves are adapting and evolving. In 2025, healthcare providers and payors and not just AI developers will be responsible for ensuring discrimination does not occur from the use of clinical algorithms and other AI solutions. While the FDA has its own guidelines for clinical AI performance testing, there is no industry standard platform for doctors or developers to use on their own. Gesund.ai has spent years creating a clinical AI validation software suite now used across different healthcare settings. It encompasses many different FDA-aligned feature sets relevant for real-world deployment. Now, the company is opening up the library of methodologies and frameworks used in combination with its validation engine for anyone to use, update and edit. “One goal of open sourcing this library is to rally communities together to update, improve and expand standards and methodologies as the field evolves,” said Dr. Enes Hosgor, CEO and founder of Gesund.ai. “No one company can or should do it alone.” Called Gesund Validate, Healthcare, AI and industry professionals can access it now at this LINK . Validate is open source and has many benefits for AI developers and healthcare providers, like: Covers the clinical AI solutions physicians use, like radiology, because it is built on unstructured multimodal data adopting “expert-in-the-loop” workflows and a wide range of computer vision tasks. Spots bias by analyzing model performance across patient metadata like age, gender, and race against built-in fairness and bias mitigation methodologies. FDA guidelines are the core of Gesund Validate and it can be adapted per the unique needs of a given hospital as well as to accommodate evolving laws. The news follows a year of growth and expansion for Gesund.ai including being named to CB Insights AI 100. In addition to rapid customer growth and joining preeminent public and private clinical AI organizations, the company recently expanded its data partnerships to include a wealth of real-world data from the Institute for Better Health (IBH) at Trillium Health Partners (THP), a leading health system in Toronto. About Gesund.ai Gesund is the world’s first AI assurance platform in healthcare on a mission to help bring clinical-grade AI solutions to market. Gesund uses its platform to deliver industry-leading independent third party validation of medical AI for pharma and medical device companies. Backed by marquee investors including Merck, McKesson, Northpond and 500, Gesund orchestrates the entire AI/ML lifecycle for all stakeholders by bringing models, data and experts together in a no-code environment. Its pioneering AI-native platform can be deployed on-prem, air-gapped, or in the cloud, which enables faster engagement with healthcare providers and board-certified physician experts. To learn more visit www.gesund.ai . #####

Gesund.ai Frequently Asked Questions (FAQ)

  • When was Gesund.ai founded?

    Gesund.ai was founded in 2021.

  • Where is Gesund.ai's headquarters?

    Gesund.ai's headquarters is located at 47 Thorndike Street, Cambridge.

  • What is Gesund.ai's latest funding round?

    Gesund.ai's latest funding round is Incubator/Accelerator.

  • How much did Gesund.ai raise?

    Gesund.ai raised a total of $2.25M.

  • Who are the investors of Gesund.ai?

    Investors of Gesund.ai include CancerX Startup Accelerator, Northpond Ventures, 500 Emerging Europe, Teknoloji ve İnovasyon Fonu, Invest 101 and 4 more.

  • Who are Gesund.ai's competitors?

    Competitors of Gesund.ai include Segmed and 2 more.

  • What products does Gesund.ai offer?

    Gesund.ai's products include Validation-as-a-Service and 1 more.

  • Who are Gesund.ai's customers?

    Customers of Gesund.ai include ScanDiags.

Loading...

Compare Gesund.ai to Competitors

Q
QMENTA

QMENTA is a medical imaging platform. The cloud-based platform uses information from magnetic resonance imaging (MRI) and computerized tomography (CT) brain images to improve drug development and clinical care for brain diseases. It was founded in 2013 and is based in Boston, Massachusetts.

Omniscient Neurotechnology Logo
Omniscient Neurotechnology

Omniscient Neurotechnology specializes in brain mapping technologies and operates in the healthcare technology sector. The company provides software solutions that analyze complex brain network data, known as connectomics, to support neurosurgeons and researchers in understanding and treating brain-related disorders. These solutions leverage artificial intelligence and cloud computing to process neural data and generate personalized brain maps for informed surgical planning and research insights. It was founded in 2019 and is based in Haymarket, Australia.

T
Translational Imaging Innovations

Translational Imaging Innovations is a company focused on integrating imaging science workflows and advanced analytics for research and clinical trials in the ophthalmology and vision science sector. The company offers a unified suite of applications that address the workflow and data management needs of ophthalmology and vision science investigators in a secure environment. These applications help manage study workflows, organize complex data and images, and simplify compliance processes. It was founded in 2019 and is based in Hickory, North Carolina.

BenchSci Logo
BenchSci

Benchsci develops a research intelligence platform. It uses artificial intelligence and machine learning to translate closed and open-access data into recommendations for specific experiments regarding antibody extraction. Benchsci was formerly known as Scinapsis. It was founded in 2015 and is based in Toronto, Canada.

m
maiData

maiData is a company focused on service automation in the technology sector. The company offers software solutions that automate service tasks, monitor product performance in the field, and provide secure remote access to products, aiming to improve quality, customer satisfaction, and operational efficiency. maiData primarily serves sectors that require service automation and remote product monitoring. It was founded in 2020 and is based in Menlo Park, California.

O
OneMedNet

OneMedNet is a company focused on the healthcare and life sciences sectors. It provides research and regulatory-ready, image-centric data to life science innovators, curating and presenting data regardless of its complexity, specificity, or diversity. The company primarily serves the life sciences industry. It was founded in 2006 and is based in Eden Prairie, Minnesota.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.